7月 2026
- 首頁
- Arrotex Pharmaceuticals
7月 2026Arrotex Pharmaceuticals的市場佔有率分析
"Arrotex Pharmaceuticals is Australia’s largest generic pharmaceutical and private label over the counter (OTC) medicines company. Arrotex Pharmaceuticals was formed following the merger of Arrow Pharmaceuticals (Arrow) and Apotex Australia (Apotex)... More
Arrotex Pharmaceuticals(包含公司地區)
查看更多網站流量與參與度資訊- arrotex.com.au
Arrotex Pharmaceuticals的熱門網域總造訪量
了解Arrotex Pharmaceuticals市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Arrotex Pharmaceuticals的熱門網域平均造訪時長
分析Arrotex Pharmaceuticals參與度指標。
過去 3 個月平均造訪時長
子公司細目
Arrotex Pharmaceuticals的熱門網域平均頁面瀏覽量
了解Arrotex Pharmaceuticals如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Arrotex Pharmaceuticals
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Arrotex Pharmaceuticals Pty partnered with CStone Pharma on Jun 25th '26.Dennis Bastas, Chairman and Group Chief Executive Officer of DBG Health, the parent company of Arrotex Pharmaceuticals, said: "We are excited to be partnering with CStone to bring this innovative therapy to Australia and New Zealand.
6月 26, 2026閱讀更多
新聞Arrotex Pharmaceuticals Pty will hire Zeller as chief executive on Dec 1st '26.Zeller was previously the Australia and New Zealand country head for Swiss pharmaceutical giant Novartis before he resigned in December to take up the Arrotex role, which previously was held by Bastas.
6月 24, 2026閱讀更多
新聞Arrotex Pharmaceuticals Pty launched eye drops for presbyopia on Jun 25th '26.Arrotex to launch first eye drops for presbyopia.
6月 24, 2026閱讀更多
查看所有Arrotex Pharmaceuticals信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
